Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Eating isoflavone can help mice grow hair by increasing a growth factor.

Pregnancy reduces anxiety in rats, but finasteride reverses this effect.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Finasteride worsens stress effects on sensory processes, possibly linking to anxiety/depression.

Finasteride helps induce ovulation in nonresponder PCOS women.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Estrogens and progesterone are key in regulating melasma pigmentation.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.